Category
Tetrabenazine
CAS Number
3466-75-9
Molecular Formula
C₁₉H₂₉NO₃
Molecular Weight
319.44 g/mol
Synonym

9,10-dimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-ol; 3-Isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-ol; 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-ol; 2H-Benzo[a]quinolizin-2-ol, 1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy; Dihydrotetrabenazine; Hydroxy Tetrabenazine

Keywords
Aliphatics
Heterocycles
Intermediates
Pharmaceutical Standards
Aromatics
Fine Chemicals
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Tetrabenazine Alcohol Impurity refers to trace amounts of alcohol-related by-products or residual solvents that may be present during the synthesis or degradation of tetrabenazine, a medication used mainly for treating hyperkinetic movement disorders such as chorea in Huntington’s disease. These impurities can arise from manufacturing steps involving alcohol-based reagents or solvents. Regulatory guidelines require strict control and monitoring of such impurities because even small quantities may affect drug safety, stability, or quality. In pharmaceutical quality testing, they are identified and quantified using analytical techniques like chromatography to ensure the final product meets acceptable safety standards.